Immunitybio, Inc.
IBRX
Revenue
7.55M
▲1.45M▲23.68%
3 Months ChangeAssets
382.93M
▲18.36M▲5.04%
3 Months ChangeLiabilities
871.06M
▼-237.67M▼-21.44%
3 Months ChangeFree Cash Flow
-108.24M
▼-15.51M▼-16.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001326110-24-000103
2024-07-18
Form 8-K
ID: 0001326110-24-000093
2024-06-12
Form 8-K
ID: 0001326110-24-000069
2024-05-09
Form 10-Q
ID: 0001326110-24-000064
2024-04-23
Form 8-K
ID: 0001326110-24-000040
2024-02-26
Form 8-K
ID: 0001193125-24-044886
2024-01-02
Form 8-K
ID: 0001326110-24-000003
2023-11-09
Form 10-Q
ID: 0001326110-23-000147
2023-09-11
Form 8-K
ID: 0001326110-23-000121
2023-09-01
Form 8-K
ID: 0001326110-23-000112